evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract
5629,GENE_SUMMARY,,"BCL6, a transcriptional repressor involved in immune cell development, is frequently altered by chromosomal translocations in lymphomas.",,2017-10-23,,604,BCL6,B-cell CLL/lymphoma 6,True,ENST00000232014,NM_001706.4,ZBTB27,ZNF51,BCL6A,LAZ3,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5630,GENE_BACKGROUND,,"BCL6 (B-cell CLL/lymphoma 6) encodes a zinc-finger transcription factor that is considered a transcriptional repressor due to its N-terminal POZ (Pox virus and Zinc finger) domain (PMID: 9019154). BCL6 regulates a general transcriptional program of genes involved in lymphocyte activation, differentiation, cell cycle progression and apoptosis and suppresses terminal differentiation of germinal center B-cells (PMID: 10981963, 11452114). Downregulation of BCL6 is necessary for further B-cell differentiation (PMID: 18452090). BCL6 is a proto-oncogene located on chromosome arm 3q27, which is commonly translocated in diffuse large B-cell lymphoma (DLBCL) and non-Hodgkin's lymphoma (PMID: 15202519, 8167331). This translocation, as well as BCL6 somatic mutations found in DLBCL, glioblastoma multiforme (GBM) and breast cancer, are proposed to deregulate BCL6 expression, resulting in its oncogenic potential (PMID: 25038272, 18452090, 24662818). In vitro studies have shown that inhibition of BCL6 results in reduced cell viability and increased apoptosis, and thus BCL6 has been proposed as a therapeutic target (PMID: 24662818).",,2017-03-01,,604,BCL6,B-cell CLL/lymphoma 6,True,ENST00000232014,NM_001706.4,ZBTB27,ZNF51,BCL6A,LAZ3,False,15202519,Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6.,Leukemia &amp; lymphoma,2003,44 Suppl 3,,S5-12,Pasqualucci L et al,,,Pasqualucci L et al. Leukemia &amp; lymphoma. 2003;44 Suppl 3()S5-12.,,11452114,"Arrested differentiation, the self-renewing memory lymphocyte, and vaccination.","Science (New York, N.Y.)",2018-07-13T20:01:00,293,5528,248-50,Fearon DT et al,,,0001-07-13,,8167331,"LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients.",Blood,0001-05-01,83,9,2423-7,Bastard C et al,,,0001-05-01,,24662818,The transcriptional modulator BCL6 as a molecular target for breast cancer therapy.,Oncogene,2018-02-26T20:15:00,34,9,1073-82,Walker SR et al,doi: 10.1038/onc.2014.61,,0001-02-26,,18452090,Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas.,Leukemia &amp; lymphoma,2018-05-01T20:08:00,49,5,874-82,Parekh S et al,doi: 10.1080/10428190801895345,,0001-05-01,,25038272,Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme.,Cancer letters,2018-10-10T20:14:00,353,True,41-51,Ruggieri S et al,doi: 10.1016/j.canlet.2014.06.017,,0001-10-10,,10981963,"BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.",Immunity,2018-08-01T20:00:00,13,2,199-212,Shaffer AL et al,,,2018-08-01T02:12:00,,9019154,The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.,Cell growth &amp; differentiation : the molecular biology journal of the American Association for Cancer Research,0001-12-01,6,12,1495-503,Deweindt C et al,,,2017-12-01T05:03:00,
